Visualising neuroinflammation in post-stroke patients: A comparative pet study with the tspo molecular imaging biomarkers [ 11C]PK11195 and [ 11C]vinpocetine

Current Radiopharmaceuticals

Volumn 5, Issue 1, 2012, Pages 19-28

  Gulyás, Balázs ^a   Tóth, Miklós ^a   Vas, Ádám ^b   Shchukin, Evgeni ^a   Kostulas, Konstantinos ^c   Hillert, Jan ^c   Halldin, Christer ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b GEDEON RICHTER LTD   (Hungary)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

18 kD translocator protein (TSPO); 11C pk11195; 11C vipocetine; Microglia; Molecular imaging biomarker; Peripheral benzodiazepine receptor (PBR); Positron emission tomography (PET); Radioligand; Stroke

Indexed keywords

N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; VINPOCETINE; VINPOCETINE C 11;

ADULT; AGED; ARTICLE; CASE REPORT; DRUG BINDING; DRUG DISTRIBUTION; DRUG STRUCTURE; DRUG UPTAKE; HUMAN; IC 50; INTERMETHOD COMPARISON; MALE; MOLECULAR IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; STROKE; STROKE PATIENT;

AGED; BINDING SITES; BIOLOGICAL MARKERS; CARBON RADIOISOTOPES; ENCEPHALITIS; HUMANS; ISOQUINOLINES; MALE; MIDDLE AGED; MOLECULAR IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, GABA; STROKE; VINCA ALKALOIDS; YOUNG ADULT;

EID: 83455212272     PISSN: 18744710     EISSN: 18744729     Source Type: Journal    
DOI: 10.2174/1874471011205010019     Document Type: Article

References (67)

1. Lang, S. The role of peripheral benzodiazepine receptors (PBRs) in CNS pathophysiology. Curr. Med. Chem., 2002, 9, 1411-1415.
2. Papadopoulos, V. Peripheral benzodiazepine receptor: structure and function in health and disease. Ann. Pharm. Fr., 2003, 61, 30-50.
3. Chen, M.K.; Guilarte, T.R. Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol. Ther., 2008, 118, 1-17.
4. Mrak, R.E.; Griffin, W.S. Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging, 2005, 26, 349-354.
5. Mouton, P.R.; Long, J.M.; Lei, D.L.; Howard, V.; Jucker, M.; Calhoun, M.E.; Ingram, D.K. Age and gender effects on microglia and astrocyte numbers in brains of mice. Brain Res., 2002, 22, 30-35.
6. Peters, A. Structural changes in the normally aging cerebral cortex of primates. Prog. Brain Res., 2002, 136, 455-465.
7. Batarseh, A.; Papadopoulos, V. Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states. Mol. Cell. Endocrinol., 2010, 327, 1-12.
8. Gulyás, B.; Vas, A.; Tóth, M.; Takano, A.; Varrone, A.; Cselényi, Z.; Schain, M.; Mattsson, P.; Halldin, C. Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C]vinpocetine. Neuroimage, 2011, 56, 1111-2121.
9. Venneti, S.; Lopresti, B.J.; Wiley, C.A. The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging. Prog. Neurobiol., 2006, 80, 308-322.
10. Papadopoulos, V.; Lecanu, L. Translocator protein (18 kDa) TSPO: an emerging therapeutic target in neurotrauma. Exp. Neurol., 2009, 219, 53-57.
11. Benavides, J.; Malgouris, C.; Imbault, F.; Begassat, F.; Uzan, A.; Renault, C.; Dubroeucq, M.C.; Gueremy, C.; Le Fur, G. Peripheral type" benzodiazepine binding sites in rat adrenals: binding studies with [3H]PK 11195 and autoradiographic localization. Arch. Int. Pharmacodyn. Ther., 1983, 266, 38-49.
12. Benavides, J.; Quarteronet, D.; Imbault, F.; Malgouris, C.; Uzan, A.; Renault, C.; Dubroeucq, M.C.; Gueremy, C.; Le Fur, G. Labelling of "peripheral-type" benzodiazepine binding sites in the rat brain by using [3H]PK11195, an isoquinoline carboxamide derivative: kinetic studies and autoradiographic localization. J. Neurochem., 1983, 41, 1744-1750.
13. Le Fur, G.; Perrier, M.L.; Vaucher, N.; Imbault, F.; Flamier, A.; Benavides, J.; Uzan, A.; Renault, C.; Dubroeucq, M.C.; Guérémy, C. Peripheral benzodiazepine binding sites: effect of PK 11195, 1- (2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3- isoquinolinecarboxamide. I. In vitro studies. Life Sci., 1983, 32, 1839-1847.
14. Le Fur, G.; Guilloux, F.; Rufat, P.; Benavides, J.; Uzan, A.; Renault, C.; Dubroeucq, M.C.; Guérémy, C. Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-(1- methylpropyl)-3 isoquinolinecarboxamide. II. In vivo studies. Life Sci., 1983, 32, 1849-1856.
15. Hashimoto, K.; Inoue, O.; Suzuki, K.; Yamasaki, T.; Kojima, M. Synthesis and evaluation of 11C-PK 11195 for in vivo study of peripheral-type benzodiazepine receptors using positron emission tomography. Ann. Nucl. Med., 1989, 3, 63-71.
16. Pike, V.W.; Halldin, C.; Crouzel, C.; Barré, L.; Nutt, D.J.; Osman, S.; Shah, F.; Turton, D.R.; Waters, S.L. Radioligands for PET studies of central benzodiazepine receptors and PK (peripheral benzodiazepine) binding sites - current status. Nuclear Medicine and Biology, 1993, 20, 503-525.
17. Vowinckel, E.; Reutens, D.; Becher, B.; Verge, G.; Evans, A.; Owens, T.; Antel, JP. PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J. Neurosci. Res., 1997, 50, 345-353.
18. Banati, R.B.; Goerres, G.W.; Myers, R.; Gunn, R.N.; Turkheimer, F.E.; Kreutzberg, G.W.; Brooks, D.J.; Jones, T.; Duncan, J.S. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology, 1999, 53, 2199-2203.
19. Banati, R.B.; Newcombe, J.; Gunn, R.N.; Cagnin, A.; Turkheimer, F.; Heppner, F.; Price, G.; Wegner, F.; Giovannoni, G.; Miller, D.H.; Perkin, G.D.; Smith, T.; Hewson, A.K.; Bydder, G.; Kreutzberg, G.W.; Jones, T.; Cuzner, M.L.; Myers, R. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain, 2000, 123, 2321-2337.
20. Gerhard, A.; Neumaier, B.; Elitok, E.; Glatting, G.; Ries, V.; Tomczak, R.; Ludolph, A.C.; Reske, S.N. In vivo imaging of activated microglia using [11C]PK11195 and positron emission tomography in patients after ischemic stroke. Neuroreport, 2000, 11, 2957-2960.
21. Gerhard, A.; Banati, R.B.; Goerres, G.B.; Cagnin, A.; Myers, R.; Gunn, R.N.; Turkheimer, F.; Good, C.D.; Mathias, C.J.; Quinn, N.; Schwarz, J.; Brooks, D.J. [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology, 2003, 61, 686-689.
22. Gerhard, A.; Schwarz, J.; Myers, R.; Wise, R.; Banati, R.B. Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study. Neuroimage, 2005, 24, 591-595.
23. Cagnin, A.; Gerhard, A.; Banati, R.B. The concept of in vivo imaging of neuroinflammation with [11C](R)-PK11195 PET. Ernst Schering Res. Found. Workshop, 2002, 39, 179-191.
24. Cagnin, A.; Brooks, D.J.; Kennedy, A.M.; Gunn, R.N.; Myers, R.; Turkheimer, F.E.; Jones, T.; Banati, R.B. In-vivo measurement of activated microglia in dementia. Lancet, 2001, 358, 461-467.
25. Price, C.J.; Wang, D.; Menon, D.K.; Guadagno, J.V.; Cleij, M.; Fryer, T.; Aigbirhio, F.; Baron, J.C.; Warburton, E.A. Intrinsic activated microglia map to the peri-infarct zone in the subacute phase of ischemic stroke. Stroke, 2006, 37, 1749-1753.
26. Kassiou, M., Meikle, S.R.; Banati, R.B. Ligands for peripheral benzodiazepine binding sites in glial cells. Brain Res. Brain Res. Rev., 2005, 48, 207-210.
27. Boutin, H.; Chauveau, F.; Thominiaux, C.; Grégoire, M.C.; James, M.L.; Trebossen, R.; Hantraye, P.; Dollé, F.; Tavitian, B.; Kassiou M. 11C-DPA-713: a novel peripheral benzodiazepine receptor PET ligand for in vivo imaging of neuroinflammation. J. Nucl. Med., 2007, 48, 573-581.
28. Imaizumi, M.; Kim, H.J.; Zoghbi, S.S.; Briard, E.; Hong, J.; Musachio, J.L.; Ruetzler, C.; Chuang, D.M.; Pike, V.W.; Innis, R.B.; Fujita, M. PET imaging with [11C]PBR28 can localize and quantify upregulated peripheral benzodiazepine receptors associated with cerebral ischemia in rat. Neurosci. Lett., 2007, 411, 200-205.
29. James, M.L.; Fulton, R.R.; Vercoullie, J.; Henderson, D.J.; Garreau, L.; Chalon, S.; Dolle, F.; Costa, B.; Guilloteau, D.; Kassiou, M. DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization. J. Nucl. Med., 2008, 49, 814-822.
30. Dollé, F.; Luus, C.; Reynolds, A.; Kassiou, M. Radiolabelled molecules for imaging the translocator protein (18 kDa) using positron emission tomography. Curr. Med. Chem., 2009, 16, 2899-2923.
31. Endres, C.J.; Pomper, M.G.; James, M.; Uzuner, O.; Hammoud, D.A.; Watkins, C.C.; Reynolds, A.; Hilton, J.; Dannals, R.F.; Kassiou, M. Synthesis of [(125)I]iodoDPA-713: a new probe for imaging inflammation. J. Nucl. Med., 2009, 50, 1276-1282.
32. Higuchi, M. Visualization of brain amyloid and microglial activation in mouse models of Alzheimer's disease. Curr. Alzheimer Res., 2009, 6, 137-143.
33. Martín, A., Boisgard, R.; Thézé, B.; Van Camp, N.; Kuhnast, B.; Damont, A.; Kassiou, M.; Dollé, F.; Tavitian, B. Evaluation of the PBR/TSPO radioligand [(18)F]DPA-714 in a rat model of focal cerebral ischemia. J. Cereb. Blood Flow Metab., 2010, 30, 230-241.
34. Doorduin, J.; Klein, H.C.; de Jong, J.R.; Dierckx, R.A.; de Vries, E.F. Evaluation of [11C]-DAA1106 for imaging and quantification of neuroinflammation in a rat model of herpes encephalitis. Nucl. Med. Biol., 2010, 37, 9-15.
35. Takano, A.; Arakawa, R.; Ito, H.; Tateno, A.; Takahashi, H.; Matsumoto, R.; Okubo, Y., Suhara, T. Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106. Int. J. Neuropsychopharmacol., 2010, 130, 1-8.
36. Bönöczk, P.; Gulyás, B.; Adam-Vizi, V.; Nemes, A.; Kárpáti, E.; Kiss, B.; Kapás, M.; Szántay, C.; Koncz, I.; Zelles, T.; Vas, Á. Vinpocetine: a compund in cerebrovascular disorders and neuroprotection. Brain Res. Bull., 2000, 53, 245-254.
37. Medina, A.E. Vinpocetine as a potent antiinflammatory agent. Proc. Natl. Acad. Sci. USA, 2010, 107, 9921-9922.
38. Jeon, K.I.; Xu, X.; Aizawa, T.; Lim, J.H.; Jono, H.; Kwon, D.S.; Abe, J.; Berk, B.C.; Li, J.D.; Yan, C. Vinpocetine inhibits NFkappaB- dependent inflammation via an IKK-dependent but PDEindependent mechanism. Proc. Natl. Acad. Sci. USA, 2010, 107, 9795-9800.
39. Rupprecht, R.; Papadopoulos, V.; Rammes, G.; Baghai, T.C.; Fan, J.; Akula, N.; Groyer, G.; Adams, D.; Schumacher, M. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat. Rev. Drug Discov., 2010, 9, 971-988.
40. Szakáll, S.; Boros, I.; Balkay, L.; Emri, M.; Fekete, I.; Kerényi, L.; Lehel, S.; Márián, T.; Molnár, T.; Varga, J.; Galuska, L.; Trón, L.; Csiba L.; Gulyás, B. The cerebral effects of a single-dose intravenous vinpocetine in chronic stroke patients: A PET study. J. Neuroimaging, 1998, 8, 197-204.
41. Gulyás, B.; Csiba, L.; Kerényi, L.; Galuska, L.; Trón, L. PET studies on chronic stroke patients before and after a single-dose intravenous Cavinton infusion. In: Positron emission tomography: A critical assessment of recent trends; Gulyás, B. and Müller-Gärtner, H. W., Eds.; Kluwer Academic Publisher; Dordrecht, 1998, pp. 291-306.
42. Szilágyi, G.; Nagy, Z.; Balkay, L.; Boros, I.; Emri, M.; Lehel, S.; Márián, T.; Molnár, T.; Szakáll, S.; Trón, L.; Bereczki, D.; Csiba, L.; Fekete, I.; Kerényi, L.; Galuska, L.; Varga, J.; Bönöczk, P.; Vas, A.; Gulyás, B. Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study. J. Neurol. Sci., 2005, 229-230, 275-284.
43. Hall, H.; Varnäs, K.; Sandell, J.; Halldin, C.; Farde, L.; Vas, Á.; Kárpáti E.; Gulyás, B. Autoradiographic evaluation of [11C]vinpocetine binding in the human postmortem brain. Acta Biol. Hung., 2002, 53, 59-66.
44. Gulyás, B.; Halldin, C.; Karlsson, P.; Chou, Y.-H.; Swahn, C.-G.; Bönöczk, P.; Farde, L. Brain uptake and plasma metabolism of 11C-vinpocetine. A PET study in cynomolgous monkey. J. Neuroimaging, 1999, 9, 217-222.
45. Gulyás, B.; Sóvágó, J.; Sandell, J.; Halldin, C.; Cselényi, Z.; Vas, Á.; Kiss, B.; Kárpáti, E.; Farde, L. Drug distribution in man: a positron emission tomography study after oral administration of the labelled europrotective drug vinpocetine. Eur. J. Nucl. Med., 2002, 29, 1031-1038.
46. Gulyás, B.; Halldin, C.; Sandell, J.; Swahn, C.-G.; Bönöck, P.; Kiss, B.; Vas, Á.; Cselényi, Z.; Vas, Á.; Farde, L. PET studies on the uptake and regional distribution of [11C]vinpocetine in human subjects. Acta Neurol. Scand., 2002, 106, 325-332.
47. 11C]Vinpocetine: a prospective peripheral benzodiazepine receptor ligand for primate PET studies. J. Neurol. Sci., 2002, 15, 219-223.
48. Vas, A.; Gulyás, B. Eburnamine derivatives and the brain. Med. Res. Rev., 2008, 5, 737-757.
49. Vas, A.; Shchukin, Y.; Karrenbauer, V.D.; Cselényi, Z.; Kostulas, K.; Hillert, J.; Savic, I.; Takano, A.; Halldin, C.; Gulyás, B. Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients. J. Neurol. Sci., 2008, 264, 9-17.
50. Chauveau, F.; Van Camp, N.; Dollé, F.; Kuhnast, B.; Hinnen, F.; Damont, A.; Boutin, H.; James, M.; Kassiou, M.; Tavitian, B. Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation. J. Nucl. Med., 2009, 50, 468-476.
51. Cremer, J.E.; Hume, S.P.; Cullen, B.M.; Myers, R.; Manjil, L.G.; Turton, D.R.l. The distribution of radioactivity in brains of rats given [Nmethyl-11C]PK 11195 in vivo after induction of a cortical ischaemiclesion. Nucl. Med. Biol., 1992, 9, 159-166.
52. Wienhard, K.; Dahlbom, M.; Eriksson, L.; Michel, C.; Bruckbauer, T.; Pietrzyk, U.; Heiss, W.D. The ECAT EXACT HR: performance of a new high resolution positron scanner. J. Comput. Assist. Tomogr., 1994, 18, 110-118.
53. Bergström, M.; Boëthius, J.; Eriksson, L.; Greitz, T.; Ribbe, T.; Widén, L. Head fixation device for reproducible position alignment in transmission CT and positron emission tomography. J. Comput. Assist. Tomogr., 1981, 5, 136-141.
54. Roland, P.E.; Graufelds, C.J.; Wåhlin, J.; Ingelman, L.; Andersson, M.; Ledberg, A.; Pedersen, J.; Åkerman, S.; Dabringhaus, A.; Zilles, K. Human brain atlas: for high resolution functional and anatomical mapping. Human Brain Mapp., 1994, 1, 173-184.
55. Logan, J.; Fowler, J.S.; Volkow, N.D.; Wang, G.J.; Ding, Y.S.; Alexoff, D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab., 1996, 16, 834-840.
56. Cselényi, Z.; Olsson, H.; Farde, L.; Gulyás, B. Wavelet-aided parametric mapping of cerebral dopamine D2 receptors using the high affinity PET radioligand [11C]FLB 457. Neuroimage, 2002, 17, 47-60.
57. Weinstein, J.R.; Koerner, I.P.; Möller, T. Microglia in ischemic brain injury. Future Neurol., 2010, 5, 227-246.
58. Walberer, M.; Dennin, M.A.; Simard, M.L.; Emig, B.; Jander, S.; Fink, G.R.; Schroeter, M. Dynamics of neuroinflammation in the macrosphere model of arterio-arterial embolic focal ischemia: an approximation to human stroke patterns. Exp. Transl. Stroke Med., 2010, 2, 22.
59. Pappata, S.; Levasseur, M.; Gunn, R.N.; Myers, R.; Crouzel, C.; Syrota, A.; Jones, T.; Kreutzberg, G.W.; Banati, R.B. Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195. Neurology, 2000, 55, 1052-1054.
60. Valtier, D.; Malgouris, C.; Gilbert, J.C.; Guicheney, P.; Uzan, A.; Gueremy, C.; Le Fur, G.; Saraux, H.; Meyer, P. Binding sites for a peripheral type benzodiazepine antagonist ([3H]PK 11195) in human iris. Neuropharmacology, 1987, 26, 549-552.
61. Radlinska, B.A.; Ghinani, S.A.; Lyon, P.; Jolly, D.; Soucy, J.P.; Minuk, J.; Schirrmacher, R.; Thiel, A. Multimodal microglia imaging of fiber tracts in acute subcortical stroke. Ann Neurol., 2009, 66, 825-832.
62. Thiel, A.; Radlinska, B.A.; Paquette, C.; Sidel, M.; Soucy, J.P.; Schirrmacher, R.; Minuk, J. The temporal dynamics of poststroke neuroinflammation: a longitudinal diffusion tensor imaging-guided PET study with 11C-PK11195 in acute subcortical stroke. J. Nucl. Med., 2010, 51, 1404-1412.
63. Rao, V.L.; Butterworth, R.F. Characterization of binding sites for the omega3 receptor ligands [3H]PK11195 and [3H]RO5-4864 in human brain. Eur. J. Pharmacol., 1997, 340, 89-99.
64. Owen, D.R.; Howell, O.W.; Tang, S.P.; Wells, L.A.; Bennacef, I.; Bergström, M.; Gunn, R.N.; Rabiner, E.A.; Wilkins, M.R.; Reynolds, R.; Matthews, P.M.; Parker, C.A. Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation. J. Cereb. Blood Flow Metab., 2010, 30, 1608-1618.
65. Owen, D.R.; Gunn, R.N.; Rabiner, E.A.; Bennacef, I.; Fujita, M.; Kreisl, W.C.; Innis, R.B.; Pike, V.W.; Reynolds, R.; Matthews, P.M.; Parker, C.A. Mixed-affinity binding in humans with 18-kDa translocator protein ligands. J. Nucl. Med., 2011, 52, 24-32.
66. Kreisl, W.C.; Fujita, M.; Fujimura, Y.; Kimura, N.; Jenko, K.J.; Kannan, P.; Hong, J.; Morse, C.L.; Zoghbi, S.S.; Gladding, R.L.; Jacobson, S.; Oh, U.; Pike, V.W.; Innis, R.B. Comparison of [(11)C]-(R)-PK 11195 and [(11)C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker. Neuroimage, 2010, 49, 2924-2932.
67. Shimizu, K.; Murata, T.; Watanabe, Y.; Sato, C.; Morita, H.; Tagawa, T. Characterization of phosphodiesterase 1 in human malignant melanoma cell lines. Anticancer Res., 2009, 29, 1119-1122.